172 related articles for article (PubMed ID: 11689641)
1. Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection.
Thiebot H; Louache F; Vaslin B; de Revel T; Neildez O; Larghero J; Vainchenker W; Dormont D; Le Grand R
J Virol; 2001 Dec; 75(23):11594-602. PubMed ID: 11689641
[TBL] [Abstract][Full Text] [Related]
2. Early bone marrow hematopoietic defect in simian/human immunodeficiency virus C2/1-infected macaques and relevance to advance of disease.
Yamakami K; Honda M; Takei M; Ami Y; Kitamura N; Nishinarita S; Sawada S; Horie T
J Virol; 2004 Oct; 78(20):10906-10. PubMed ID: 15452210
[TBL] [Abstract][Full Text] [Related]
3. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
4. Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
Bourry O; Brochard P; Souquiere S; Makuwa M; Calvo J; Dereudre-Bosquet N; Martinon F; Benech H; Kazanji M; Le Grand R
AIDS; 2009 Feb; 23(4):447-54. PubMed ID: 19240457
[TBL] [Abstract][Full Text] [Related]
5. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
[TBL] [Abstract][Full Text] [Related]
6. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
7. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
[TBL] [Abstract][Full Text] [Related]
8. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow monocyte/macrophages are an early cellular target of pathogenic and nonpathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques.
Mandell CP; Jain NC; Miller CJ; Dandekar S
Lab Invest; 1995 Mar; 72(3):323-33. PubMed ID: 7898051
[TBL] [Abstract][Full Text] [Related]
10. Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251.
Gay W; Lauret E; Boson B; Larghero J; Matheux F; Peyramaure S; Rousseau V; Dormont D; De Maeyer E; Le Grand R
Retrovirology; 2004 Sep; 1():29. PubMed ID: 15447786
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy.
Benlhassan-Chahour K; Penit C; Dioszeghy V; Vasseur F; Janvier G; Rivière Y; Dereuddre-Bosquet N; Dormont D; Le Grand R; Vaslin B
J Virol; 2003 Dec; 77(23):12479-93. PubMed ID: 14610172
[TBL] [Abstract][Full Text] [Related]
12. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates.
Goldstein S; Ourmanov I; Brown CR; Plishka R; Buckler-White A; Byrum R; Hirsch VM
J Virol; 2005 Apr; 79(8):5153-62. PubMed ID: 15795299
[TBL] [Abstract][Full Text] [Related]
13. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
[TBL] [Abstract][Full Text] [Related]
14. Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1).
Stephens EB; Joag SV; Atkinson B; Sahni M; Li Z; Foresman L; Adany I; Narayan O
Virology; 1997 Aug; 234(2):328-39. PubMed ID: 9268165
[TBL] [Abstract][Full Text] [Related]
15. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
16. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
Luciw PA; Mandell CP; Himathongkham S; Li J; Low TA; Schmidt KA; Shaw KE; Cheng-Mayer C
Virology; 1999 Oct; 263(1):112-27. PubMed ID: 10544087
[TBL] [Abstract][Full Text] [Related]
17. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.
Harouse JM; Tan RC; Gettie A; Dailey P; Marx PA; Luciw PA; Cheng-Mayer C
Virology; 1998 Aug; 248(1):95-107. PubMed ID: 9705259
[TBL] [Abstract][Full Text] [Related]
18. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
Kumar A; Buch S; Foresman L; Bischofberger N; Lifson JD; Narayan O
Virology; 2001 Jan; 279(1):97-108. PubMed ID: 11145893
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
20. Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.
Smith MS; Foresman L; Lopez GJ; Tsay J; Wodarz D; Lifson JD; Page A; Wang C; Li Z; Adany I; Buch S; Bischofberger N; Narayan O
Virology; 2000 Nov; 277(2):306-15. PubMed ID: 11080478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
